surmount 1 tirzepatide ESC 2025: post-hoc SURMOUNT-5 data affirms tirzepatide's lead in CVD risk reduction SURMOUNT-1: Adults achieve weight loss

For subcutaneous tirzepatide injections in the thigh, the optimal range is 27-30 gauge

For practical support, review hydration, smaller meals, and GLP-1 supplement basics

Weaning off tirzepatide requires gradual dose reduction, not abrupt cessation

After an overnight fast, your morning meal is the first gallbladder stimulation of the day

The discomfort may be linked to dryness on the surface of the eye, strain from focusing (accommodative strain), or underlying inflammatory processes that require further examination to rule out more serious conditions

Its best to discuss your options with a healthcare provider who can help you determine the best course of action